B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 5, 2007, Pages 1179-1187

  Chikovani, Omar ^a   Hsu, Jong Hau ^a,c   Keller, Roberta ^a   Karl, Tom R ^a,b   Azakie, Anthony ^a,b   Adatia, Ian ^a,b   Oishi, Peter ^a   Fineman, Jeffrey R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BLOOD OXYGEN TENSION; CLINICAL ARTICLE; EXTRACORPOREAL OXYGENATION; FEMALE; HEART SURGERY; HORMONE BLOOD LEVEL; HUMAN; INFANT; INTENSIVE CARE; LACTATE BLOOD LEVEL; MALE; MORTALITY; NEWBORN; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; EXTRACORPOREAL CIRCULATION; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 35448984889     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.04.023     Document Type: Article

References (37)

1. Baslaim G., Bashore J., Al-Malki F., and Jamjoom A. Can the outcome of pediatric extracorporeal membrane oxygenation after cardiac surgery be predicted?. Ann Thorac Cardiovasc Surg 12 (2006) 21-27
2. Raithel S.C., Pennington D.G., Boegner E., Fiore A., and Weber T.R. Extracorporeal membrane oxygenation in children after cardiac surgery. Circulation 86 5 Suppl (1992) II305-II310
3. Huang S.C., Wu E.T., Chen Y.S., Chang C.I., Chiu I.S., Chi N.H., et al. Experience with extracorporeal life support in pediatric patients after cardiac surgery. ASAIO J 51 (2005) 517-521
4. Ghez O., Feier H., Ughetto F., Fraisse A., Kreitmann B., and Metras D. Postoperative extracorporeal life support in pediatric cardiac surgery: recent results. ASAIO J 51 (2005) 513-516
5. Morris M.C., Ittenbach R.F., Godinez R.I., Portnoy J.D., Tabbutt S., Hanna B.D., et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med 32 (2004) 1061-1069
6. Groom R.C. Pediatric cardiopulmonary bypass devices: trends in device use for cardiopulmonary bypass and postcardiotomy support. ASAIO J 51 (2005) 525-529
7. Shen I., and Ungerleider R.M. Routine use of mechanical ventricular assist following the Norwood procedure. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 7 (2004) 16-21
8. Ungerleider R.M., Shen I., Yeh T., Schultz J., Butler R., Silberbach M., et al. Routine mechanical ventricular assist following the Norwood procedure-improved neurologic outcome and excellent hospital survival. Ann Thorac Surg 77 (2004) 18-22
9. Conrad S.A., Rycus P.T., and Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 51 (2005) 4-10
10. Yandle T.G. Biochemistry of natriuretic peptides. J Intern Med 235 (1994) 561-576
11. Doust J.A., Glasziou P.P., Pietrzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164 (2004) 1978-1984
12. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
13. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
14. Costello J.M., Goodman D.M., and Green T.P. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 7 (2006) 308-318
15. Price J.F., Thomas A.K., Grenier M., Eidem B.W., O'Brian Smith E., Denfield S.W., et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 114 (2006) 1063-1069
16. Salzberg S., Lachat M., Zund G., Oechslin E., Schmid E.R., DeBakey M., et al. Left ventricular assist device as bridge to heart transplantation-lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardiothorac Surg 24 (2003) 113-118
17. Ohata T., Sakakibara T., Takano H., and Izutani H. Plasma brain natriuretic peptide reflects left ventricular function during percutaneous cardiopulmonary support. Ann Thorac Surg 77 (2004) 164-167
18. Sodian R., Loebe M., Schmitt C., Potapov E.V., Siniawski H., Muller J., et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 38 (2001) 1942-1949
19. Thompson L.O., Skrabal C.A., Loebe M., Lafuente J.A., Roberts R.R., Akgul A., et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 123 (2005) 25-32
20. Huang S.C., Wu E.T., Ko W.J., Lai L.P., Hsu J., Chang C.I., et al. Clinical implication of blood levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support. Ann Thorac Surg 81 (2006) 2267-2272
21. Karl T.R., and Horton S.B. Ventricular assist device support in pediatric patients. In: Chang A. (Ed). Heart failure in children and young adults (2006), Saunders-Elsevier, Philadelphia 664-679
22. Wernovsky G., Wypij D., Jonas R.A., Mayer Jr. J.E., Hanley F.L., Hickey P.R., et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92 (1995) 2226-2235
23. McGrath M.F., de Bold M.L., and de Bold A.J. The endocrine function of the heart. Trends Endocrinol Metab 16 (2005) 469-477
24. Zhang Y., Carreras D., and de Bold A.J. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-l-arginine methyl ester (l-NAME) hypertension. Cardiovasc Res 57 (2003) 158-167
25. Schaub M.C., Hefti M.A., Harder B.A., and Eppenberger H.M. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75 (1997) 901-920
26. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
27. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 (2004) 505-513
28. Kuhn M., Voss M., Mitko D., Stypmann J., Schmid C., Kawaguchi N., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
29. Cowley C.G., Bradley J.D., and Shaddy R.E. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25 (2004) 336-340
30. Law Y.M., Ettedgui J., Beerman L., Maisel A., and Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 98 (2006) 520-524
31. Koch A., Zink S., and Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 27 (2006) 861-866
32. Sun L.S., Dominguez C., Mallavaram N.A., and Quaegebeur J.M. Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 129 (2005) 1104-1110
33. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
34. Shih C.Y., Sapru A., Oishi P., Azakie A., Karl T.R., Harmon C., et al. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 131 (2006) 632-638
35. Tweddell J.S., and Hoffman G.M. Postoperative management in patients with complex congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5 (2002) 187-205
36. Hoskote A., Bohn D., Gruenwald C., Edgell D., Cai S., Adatia I., et al. Extracorporeal life support after staged palliation of a functional single ventricle: subsequent morbidity and survival. J Thorac Cardiovasc Surg 131 (2006) 1114-1121
37. Cheung P.Y., Etches P.C., Weardon M., Reynolds A., Finer N.N., and Robertson C.M. Use of plasma lactate to predict early mortality and adverse outcome after neonatal extracorporeal membrane oxygenation: a prospective cohort in early childhood. Crit Care Med 30 (2002) 2135-2139